- Article
O-GlcNAc Modification Is a Promising Therapeutic Target for Diabetic Retinopathy
- Wenkang Dong,
- Laraib Imdad,
- Shengnan Xu,
- Yinli Wang,
- Chengzhi Liu,
- Shiyu Song,
- Zechuan Li,
- Ying Kong,
- Li Kong and
- Xiang Ren
Diabetic retinopathy (DR) is a very serious diabetes complication. Changes in the O-linked N-acetylglucosamine (O-GlcNAc) modification are associated with many diseases. However, its role in DR is not fully understood. In this research, we explored t...

